U.S. HMO Industry Faces Challenges and Opportunities
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 12 2026
0mins
Should l Buy UNH?
Source: NASDAQ.COM
- Rising Medical Costs: U.S. health insurers are experiencing increased medical expenses due to the resumption of deferred care and heightened demand for chronic disease management, leading to a rise in insurance claims and pressure on profit margins.
- Regulatory Uncertainty: New legislation may tighten Medicaid eligibility and reduce ACA enrollment, impacting insurers' membership and reimbursements, which forces a shift towards commercial insurance products to enhance profitability.
- Healthcare Workforce Shortage: The ongoing shortage of nurses and healthcare professionals is straining hospital operations, affecting HMOs' ability to deliver high-quality care, which could lead to customer attrition.
- M&A Strategy: HMO companies are pursuing mergers and acquisitions to expand market share and enhance competitiveness, with expected interest rate declines in 2026 likely to fuel further M&A activity, driving industry consolidation.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 324.630
Low
330.00
Averages
397.82
High
444.00
Current: 324.630
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Expectations: UnitedHealth is set to report earnings this Tuesday before market open, with market expectations indicating flat revenue year-over-year, a significant slowdown from the 9.8% growth recorded in the same quarter last year, highlighting growth challenges faced by the company.
- Revenue Performance: Last quarter, UnitedHealth reported revenues of $113.2 billion, up 12.3% year-over-year, meeting analysts' expectations; however, the full-year revenue guidance fell significantly short of analysts' forecasts, indicating uncertainty in the company's long-term growth trajectory.
- Market Sentiment: Despite UnitedHealth missing Wall Street's revenue estimates multiple times over the past two years, investor sentiment in the healthcare services sector has been positive, with average share prices rising 9.1% over the past month, while UnitedHealth's stock surged 20.2%, reflecting market optimism about its future performance.
- Analyst Views: Analysts covering UnitedHealth have generally reaffirmed their revenue estimates over the last 30 days, suggesting they expect the company to maintain stability heading into earnings, despite the pressures of slowing growth.
See More
- Oil Price Surge Amid Tensions: Renewed tensions in the Strait of Hormuz have led to rising oil prices, with the U.S. seizing an Iranian commercial ship attempting to evade a Navy blockade, potentially impacting global oil markets.
- M&A Activity on the Rise: Roofing and construction supplies distributor QXO has agreed to acquire installation firm TopBuild for $17 billion, positioning QXO as a leader in waterproofing and insulation, which is expected to significantly enhance its market share.
- Optimistic Apple Earnings Forecast: Morgan Stanley anticipates Apple will report quarterly earnings per share of $2.02 and revenue of $110.82 billion, exceeding market expectations, with analysts expressing confidence in Apple's supply chain management capabilities and maintaining a $300 price target.
- Airline Industry Hit by Fuel Costs: KLM has canceled over 150 European flights due to soaring jet fuel costs, indicating financial strain on the airline industry, which could negatively affect related companies like Boeing.
See More
- Navy Seizure Incident: President Trump announced the U.S. Navy seized an Iranian cargo ship, leading to a cautious market sentiment as investor concerns about Middle Eastern tensions rise, causing oil prices to increase and potentially impacting consumer spending.
- Oil Price Warning: The Energy Secretary warned that gas prices could remain above $3 per gallon until next year, which would negatively affect consumers already feeling the pinch of high costs, further impacting economic recovery.
- Tech and Finance Intersection: Kevin Warsh, Trump's nominee for Federal Reserve Chair, is set for a Senate confirmation hearing, and his close ties to Silicon Valley could change the interaction between tech giants and the Fed, influencing future monetary policy.
- Automotive Dealer Consolidation Trend: Data shows that the top 150 auto dealers in the U.S. increased their market share from 21.2% a decade ago to 27%, reflecting the rise of mega-dealers and the struggles of smaller competitors, potentially leading to significant industry structural changes.
See More
- Navy Seizure Incident: President Trump announced that the U.S. Navy seized an Iranian cargo ship in the Gulf of Oman, shifting market sentiment to a defensive stance as investor concerns about Middle Eastern tensions rise, leading to higher oil prices and downward pressure on stock futures.
- Oil Price Warning: Amid fears of escalating tensions in the Middle East, oil prices are rising, with the Energy Secretary warning that gas prices could remain above $3 per gallon until next year, further straining consumers already facing higher costs.
- Tech Ties and Fed: Kevin Warsh, Trump's nominee for the Federal Reserve chair, will face confirmation hearings tomorrow, with his close ties to Silicon Valley raising questions about potential access for tech moguls to the Fed, a point of significant market interest.
- Dealer Consolidation: Data shows that the top 150 car dealerships in the U.S. increased their market share from 21.2% a decade ago to 27%, reflecting a trend of consolidation that benefits larger dealers like Lithia Motors and AutoNation.
See More
- Earnings Release Date: UnitedHealth (UNH) is set to release its Q1 2023 earnings on April 21, with analysts predicting earnings per share of $6.61 and revenue of $109.66 billion, indicating the company's ongoing growth potential in the healthcare insurance sector.
- Stock Performance: Ahead of the earnings report, UnitedHealth's stock rose by 2.6% last Friday, reflecting investor optimism about the upcoming results, which could further drive the stock price upward.
- Mixed Analyst Ratings: Despite the positive expectations surrounding UnitedHealth's earnings, analysts have mixed ratings, indicating differing views on the company's future performance, which may influence investor decisions.
- Market Impact Analysis: UnitedHealth's earnings report is expected to significantly impact its stock price and overall market sentiment, especially given the multiple challenges facing the healthcare industry, with investors closely monitoring its performance to assess future investment opportunities.
See More
- Price Increase Announcement: UnitedHealth has raised its price target for shares of Star Health from $340 to $373.
- Market Impact: This adjustment reflects a positive outlook on Star Health's performance and potential growth in the market.
See More










